Performance Measure for 7 days

PAMG-1

phlIGFBP-1

CL (<25 mm)

Sensitivity (SN)

Proportion

Confidence Interval

83%

(5/6)

(35.88, 99.58)

83%

(5/6)

(35.88, 99.58)

100%

(6/6)

(54.07, 100)

Specificity (SP)

Proportion

Confidence Interval

90%*

(46/51)

(78.59, 96.74)

76%

(39/51)

(62.51, 87.21)

71%

(36/51)

(56.17, 82.51)

Positive Predictive Value (PPV)

Proportion

Confidence Interval

50%

(5/10)

(18.71, 81.29)

29%

(5/17)

(10.31, 55.96)

29%

(6/21)

(11.28, 52.17)

Negative Predictive Value (NPV)

Proportion

Confidence Interval

98%

(46/47)

(88.71, 99.95)

98%

(39/40)

(86.84, 99.94)

100%

(36/36)

(90.26, 100)

Performance Measure for 14 days

PAMG-1

phlIGFBP-1

CL (<25 mm)

Sensitivity (SN)

Proportion

Confidence Interval

67%

(6/9)

(29.93, 92.51)

67%

(6/9)

(29.93, 92.51)

78%

(7/9)

(39.99, 97.19)

Specificity (SP)

Proportion

Confidence Interval

92%

(44/48)

(80.02, 97.68)

77%

(37/48)

(62.69, 87.97)

71%

(34/48)

(55.94, 83.05)

Positive Predictive Value (PPV)

Proportion

Confidence Interval

60%

(6/10)

(26.24, 87.84)

35%

(6/17)

(14.21, 61.67)

33%

(7/21)

(14.59, 56.97)

Negative Predictive Value (NPV)

Proportion

Confidence Interval

94%

(44/47)

(82.46, 98.66)

93%

(37/40)

(79.61, 98.43)

94%

(34/36)

(81.34, 99.32)